Will ProQR Therapeutics NV (PRQR) Beat the Rest of the Stocks in the Healthcare Sector?

ProQR Therapeutics NV (PRQR) is around the top of the Healthcare sector according to InvestorsObserver. PRQR received an overall rating of 47, which means that it scores higher than 47% of stocks. Additionally, ProQR Therapeutics NV scored a 78 in the Healthcare sector, ranking it higher than 78% of stocks in that sector.

PRQR has an Overall Score of 47. Find out what this means to you and get the rest of the rankings on PRQR!

See Full PRQR Report

What do These Ratings Mean?

Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. *Investors Observer* allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 47 would rank higher than 47 percent of all stocks. These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.

What's Happening With ProQR Therapeutics NV Stock Today?

ProQR Therapeutics NV (PRQR) stock has risen 20.07% while the S&P 500 has fallen -0.09% as of 2:01 PM on Thursday, Nov 30. PRQR is up $0.27 from the previous closing price of $1.37 on volume of 591,096 shares. Over the past year the S&P 500 has gained 11.44% while PRQR is up 34.15%. PRQR lost -$0.48 per share the over the last 12 months. Click Here to get the full Stock Report for ProQR Therapeutics NV stock.